George King Single Donor Normal Plasma is fresh frozen citrated human plasma and is intended to be used as a normal control for the one-stage prothrombin time (PT) assay, the activated partial thromboplastin time (aPTT) assay and the fibrinogen assay.

George King Single Donor Normal Plasma is fresh frozen citrated human plasma and is intended to be used as a normal control for the one-stage prothrombin time (PT) assay, the activated partial thromboplastin time (aPTT) assay and the fibrinogen assay.

George King Single Donor Normal Plasma is fresh frozen citrated human plasma and is intended to be used as a normal control for the one-stage prothrombin time (PT) assay, the activated partial thromboplastin time (aPTT) assay and the fibrinogen assay.

George King Pooled Normal Plasma is fresh frozen citrated human plasma and is intended to be used as a normal control for the one-stage prothrombin time assay (PT), the activated partial thromboplastin time (aPTT) assay and the fibrinogen assay. It may also be used as the normal pooled plasma for mixing studies in the determination of a prolonged PT or aPTT.

George King Pooled Normal Plasma is fresh frozen citrated plasma and is intended to be used as a normal control for the one-stage prothrombin time assay (PT), the activated partial thromboplastin time (aPTT) assay and the fibrinogen assay. It may be used as the normal pooled plasma for mixing studies in the determination of a prolonged (PT) ad/or aPTT.

George King Pooled Normal Plasma is fresh frozen citrated plasma and is intended to be used as a normal control for the one-stage prothrombin time assay (PT), the activated partial thromboplastin time (aPTT) assay and the fibrinogen assay. It may also be used as the normal pooled plasma for mixing studies in the determination of a prolonged PT and.or aPTT.

George King Pooled Normal Plasma is fresh frozen citrated human plasma is intended to be used as a normal control for the one-stage prothrombin time assay (PT), the activated partial thromboplastin time (aPTT) assay and the fibrinogen assay. it may also be used as the normal pooled plasma for mixing studies in the determination of a prolonged (PT and/or aPTT.

George King CFD is a Congenital Factor Deficient Convenience Kit which contains five different factor deficient plasma's for product evaluation

SysCOR-40 Control Kit is a system control convenience kit containing 20 normal and 20 abnormal plasma controls to assist with instrument correlations and reagent crossover studies.

George King Factor FVII Deficient Plasma is fresh frozen citrated human plasma derived from congenital FVII Deficient donors.

George King Single Donor Normal Control Kit contains fresh frozen citrated human plasmas derived from non-medicated, non-smoking donors between the ages of 18 and 65 years of age. The kit is intended for use in establishing controlling reference ranges for coagulation assays.

George King Single Donor Normal Control Kit contains fresh frozen citrated human plasmas derived from non-medicated, non-smoking donors between the ages of 18 and 65 years of age. The kit is intended for use in establishing controlling reference ranges for coagulation assays.

George King Abnormal Correlation (AbCOR) Kit is a convenience kit containing 10 vials of select control material that can be used to correlate reagent lot numbers and/or instrument platforms. (individual product inserts are included with each kit)

George King Abnormal Correlation (AbCOR) Kit is a convenience kit containing 20 vials of select control material that can be used to correlate reagent lot numbers and/or instrument platforms. (individual product inserts are included with each kit)

The George King Coumadin® Plasma Kit is a convenience control kit that contains citrated human fresh frozen plasma from donors on Coumadin® therapy. Each kit contains control material with six different INR levels.

George King Factor V Deficient Plasma is fresh frozen citrated human plasma derived from congenital Factor V donors.

George King Factor V Deficient Plasma is fresh frozen citrated human plasma derived from congenital Factor V deficient plasma

George King Factor FVII Deficient Plasma is fresh frozen citrated human plasma derived from congenital FVII Deficient donors.

George King Factor VII Deficient Plasma is a fresh frozen citrated human plasma derived from congenital Factor VII deficient donors.

George King Factor VIII Deficient Plasma is fresh frozen citrated human plasma derived from congenital Factor VIII deficient donors.

George King Factor VIII Deficient Plasma is fresh frozen citrated human plasma derived from congenital Factor VIII Deficient donors.

George King Factor IX Deficient Plasma is fresh frozen citrated human plasma derived from congenital Factor IX deficient donors

George King Factor IX Deficient Plasma is fresh frozen citrated human plasma derived from congenital Factor IX deficient donors

George King Factor X Deficient Plasma is a fresh frozen citrated human plasma derived from congenital Factor X deficient donors.

George King Factor X Deficient Plasma is fresh frozen citrated human plasma derived from congenital Factor X deficient donors.

George King Factor XI Deficient Plasma is fresh frozen citrated human plasma derived from congenital Factor XI deficient donors.

George King Factor XI Deficient Plasma is fresh frozen citrated human plasma derived from congenital Factor XI deficient donors

George King Factor XI Deficient Plasma is fresh frozen citrated human plasma derived from congenital Factor XI deficient donors

George King Factor XI Deficient Plasma is fresh frozen citrated human plasma derived from congenital Factor XI deficient donors

George King Factor XIII Deficient Plasma is fresh frozen citrated human plasma derived from a congenital Factor XIII deficient donor.

George King Factor XIII Deficient plasma is fresh frozen human plasma derived from a congenital Factor XIII deficient donor.

George King Factor XIII Deficient Plasma is fresh frozen citrated human plasma derived from a congenital Factor XIII deficient donor.

George King von Willebrand plasma, Type 1, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 1. This plasma is intended for use as a control in the quantitative determination of von Willebrand Ag in citrated plasma.

George King von Willebrand plasma, Type 1, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 1. This plasma is intended for use as a control in the quantitative determination of von Willebrand factor antigen in citrated plasma.

George King von Willebrand, Type 2B, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 2B. This plasma is intended for use as a control in the quantitative determination of von Willebrand aG in citrated plasma.

George King von Willebrand plasma, Type 2B, is a citrated human fresh frozen plasma derived from a donor diagnosed with vWD type 2B. This plasma is intended for use as a control in the quantitative determination of von Willebrand factor antigen in citrated plasma

George King von Willebrand plasma, Type 2B, is a citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 2B. This plasma is intended for use as a control in the quantitative determination of von Willebrand factor antigen in citrated plasma.

George King von Willebrand plasma, Type 3, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 3. This plasma is intended for use as a control in the quantitative determination of von Willebrand factor antigen in citrated plasma.

George King von Willebrand plasma, Type 2A, is a citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 2A. This plasma is intended for use as a control in the quantitative determination of von Willebrand Ag in citrated plasma.

George King von Willebrand plasma, Type 2A, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 2A. This plasma is intended for use as a control in the quantitative determination of von Willebrand Ag in citrated plasma.

George King von Willebrand plasma, Type 2A, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 2A. This plasma is intended for use as a control in the quantitative determination of von Willebrand Ag in citrated plasma.

George King Factor VIII Deficient Plasma with Inhibitor is fresh frozen citrated human plasma derived from a congenital Factor VIII deficient donor who has developed an antibody to FVIII.

George King Factor VIII Deficient Plasma with Inhibitor is fresh frozen citrated human plasma derived from a congenital Factor VIII deficient donor who has developed an antibody to FVIII

George King Factor VIII Deficient Plasma with Inhibitor is fresh frozen citrated human plasma derived from a congenital Factor VIII deficient donor whohas developed an antibody to FVIII.

George King Coumadin® Plasma is citrated fresh frozen human plasma derived from donors stabilized on Coumadin® therapy and is intended for use as a control in the quantitative determination of the INR using the clottable prothrombin time assay.

George King Coumadin® Plasma is citrated fresh frozen human plasma derived from donors stabilized on Coumadin® therapy and is intended for use as a control in the quantitative determination of the INR using the clottable prothrombin time assay.

George King Coumadin® Plasma is citrated fresh frozen human plasma derived from donors stabilized on Coumadin® therapy and is intended for use as a control in the quantitative determination of the INR using the clottable prothrombin time assay.

George King Positive Lupus Anticoagulant is citrated human fresh frozen plasma derived from donors who have been diagnosed with the Anti-Phospholipid Antibody Syndrome (APS).

George King Positive Lupus Anticoagulant is citrated human fresh frozen plasma derived from donors who have been diagnosed with the Anti-Phospholipid Antibody Syndrome (APS).

George King Positive Lupus Anticoagulant is citrated fresh frozen human plasma derived from donors who have been diagnosed with the Anti-Phospholipid Antibody Syndrome (APS).